Phillip Lindsay Ross Nicolson (Phillip L R Nicolson, Phillip Lr Nicolson, P L R Nicolson)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

University Of Birmingham

University of Birmingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Of Birmingham Dec 01 2018

United Kingdom

Clinical Lecturer in Haematology :: Institute of Cardiovascular Sciences

Queen Elizabeth Hospital Birmingham Oct 01 2015

United Kingdom

Specialty Registrar :: Department of Clinical Haematology

Education History

University of Birmingham Oct 01 2015 - Jan 17 2019

United Kingdom

PHD :: Institute of Cardiovascular Sciences

University of Cambridge Medicine Sep 01 2005 - Jul 01 2008

United Kingdom

BSC :: Downing College

University of Cambridge Oct 01 2002 - Jun 01 2005

United Kingdom

BSC :: Downing College

Publications

Joshua Gardner, Simon Timothy Abrams, Cheng-Hock Toh, Alan L Parker, Charlotte Lovatt, Phillip Lindsay Ross Nicolson, Steve P Watson, Sophie Grice, Luisa Hering, Munir Pirmohamed, Dean J Naisbitt
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines. NPJ vaccines 9 (1) (2024)
Christopher W Smith, Joana Campos, Helena C Brown, Natalie J Jooss, Vanesa-Sindi Ivanova, Maan H Harbi, Lourdes Garcia Quintanilla, Sian Jossi, Marisol Perez-Toledo, Kieran Rookes, Alexander Brill, Lindsay N Theodore, Timothy D Owens, Jacob J La Stant, Matthew C Foulke, Shin Mukai, Michelle Francesco, Michael J Storek, Alexandra Hicks, Claire Langrish, Philip A Nunn, Adam F Cunningham, Abhishek Chauhan, Mark R Thomas, Stephen P Watson, Phillip Lindsay Ross Nicolson
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 & PRN473 reduces venous thrombosis formation in mice. Blood advances (2024)
Sam Sherratt-Mayhew, Phillip Lindsay Ross Nicolson
Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case report. EJHaem 5 (4) (2024)
Sam Sherratt-Mayhew, Phillip Lindsay Ross Nicolson
Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case report. EJHaem 5 (4) (2024)
Eman Hassan, Phillip Lindsay Ross Nicolson
Challenging situations in patients with cancer-associated thrombosis-Further clarification required in the British Society for Haematology guidelines. British journal of haematology (2024)
Joshua Gardner, Simon Timothy Abrams, Cheng-Hock Toh, Alan L Parker, Charlotte Lovatt, Phillip Lindsay Ross Nicolson, Steve P Watson, Sophie Grice, Luisa Hering, Munir Pirmohamed, Dean J Naisbitt
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines. NPJ vaccines 9 (1) (2024)
Joshua Gardner, Simon Timothy Abrams, Cheng-Hock Toh, Alan L Parker, Charlotte Lovatt, Phillip Lindsay Ross Nicolson, Steve P Watson, Sophie Grice, Luisa Hering, Munir Pirmohamed, Dean J Naisbitt
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines. NPJ vaccines 9 (1) (2024)
Paula Glancy, David J Sutton, Keith Gomez, Phillip Lindsay Ross Nicolson, Richard John Buka
How will UK hospitals use andexanet alfa? A review of local protocols. EJHaem 4 (1) (2023)
Paula Glancy, David J Sutton, Keith Gomez, Phillip Lindsay Ross Nicolson, Richard John Buka
How will UK hospitals use andexanet alfa? A review of local protocols. EJHaem 4 (1) (2023)
Christopher W Smith, Maan H Harbi, Lourdes Garcia Quintanilla, Kieran Rookes, Helena C Brown, Natalie S Poulter, Stephen P Watson, Phillip Lindsay Ross Nicolson, Mark R Thomas
The Btk inhibitor AB-95-LH34 potently inhibits atherosclerotic plaque-induced thrombus formation and platelet procoagulant activity. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Samantha J Montague, Christopher W Smith, Clare S Lodwick, Charlotte Stoneley, Matthew Roberts, Gillian C Lowe, William A Lester, Stephen P Watson, Phillip Lindsay Ross Nicolson
Anti-platelet factor 4 immunoglobulin G levels in vaccine-induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months. Research and practice in thrombosis and haemostasis 6 (3) (2022)
Richard John Buka, Noémi Roy, Phillip Lindsay Ross Nicolson
UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease. EJHaem 4 (1) (2022)
Richard John Buka, Noémi Roy, Phillip Lindsay Ross Nicolson
UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease. EJHaem 4 (1) (2022)
Maan H Harbi, Christopher W Smith, Fawaz O Alenazy, Phillip Lindsay Ross Nicolson, Alok Tiwari, Steve P Watson, Mark R Thomas
Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs. International journal of molecular sciences 23 (13) (2022)
Samuel Kemble, Amanda Dalby, Gillian C Lowe, Phillip Lindsay Ross Nicolson, Stephen P Watson, Yotis A Senis, Steven G Thomas, Paul Harrison
Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry. Blood advances 6 (9) (2022)
Walid Chayoua, Phillip Lindsay Ross Nicolson, Joost C M Meijers, Caroline Kardeby, Lourdes Garcia-Quintanilla, Katrien M J Devreese, Bas de Laat, Stephen P Watson, Philip G de Groot
Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome? Journal of thrombosis and haemostasis : JTH 19 (7) (2021)
Mohammed O A Altohami, Alexander Langridge, Enas Mk Shareef, Phillip Lindsay Ross Nicolson
The negative impact of the COVID-19 pandemic on UK haematology registrars' well-being and training: Results of a UK nationwide survey. EJHaem 2 (4) (2021)
Maan H Harbi, Christopher W Smith, Phillip Lindsay Ross Nicolson, Steve P Watson, Mark R Thomas
Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases. Platelets 32 (1) (2020)
Phillip Lindsay Ross Nicolson, John D Welsh, Abhishek Chauhan, Mark R Thomas, Mark L Kahn, Steve P Watson
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors. Platelets 31 (5) (2020)

Phillip Lindsay Ross Nicolson.css-eqlu8i{font-size:small;padding-left:4px;} (Phillip L R Nicolson, Phillip Lr Nicolson, P L R Nicolson)

Publication Activity (10 Years)

Top Topics

Top Venues

Phillip Lindsay Ross Nicolson (Phillip L R Nicolson, Phillip Lr Nicolson, P L R Nicolson)